Publication date: 11 October 2017
Source:Cell Host & Microbe, Volume 22, Issue 4
Author(s): Tobias Dallenga, Urska Repnik, Björn Corleis, Jacqueline Eich, Rudolph Reimer, Gareth W. Griffiths, Ulrich E. Schaible
Neutrophils represent the main infected cell population in the lungs of active tuberculosis patients. Efficient removal of infected and dying neutrophils is required to protect the surrounding tissue from bioactive neutrophil molecules and subsequent pathological sequelae. While the removal of apoptotic M. tuberculosis (Mtb)-infected cells, or efferocytosis, is considered beneficial for host defense, little is known about Mtb-infected necrotic neutrophils. We found that Mtb induces necrosis of human neutrophils in an ESX-1-dependent manner, and neutrophil-produced reactive oxygen species (ROS) drive this necrosis. Neutrophil necrosis was required for Mtb growth after uptake of infected neutrophils by human macrophages. Pharmacological inhibition of ROS production could prevent necrosis and restore the capability of macrophages to control Mtb growth, thereby identifying a potential host-directed therapy target. Taken together, necrosis represents the starting point for a vicious cycle including the uptake of infected necrotic cells by other phagocytes, Mtb growth therein, and sustained infection.
Graphical abstract
Teaser
The role of necrosis in M. tuberculosis (Mtb) infection is not explored. Dallenga et al. find that Mtb infection of neutrophils induces necrosis in an ESX-1- and ROS-dependent manner, which promotes bacterial growth when engulfed by macrophages. Pharmacological inhibition of ROS and necrosis restored control of M. tuberculosis by macrophages.http://ift.tt/2i6toHD
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου